National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 1438-1439 [06-125]
Download as PDF
<![CDATA[
1438
Federal Register / Vol. 71, No. 5 / Monday, January 9, 2006 / Notices
Bethesda, MD 20892. 301 496–1474.
Plotzp@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: December 30, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–121 Filed 1–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Dated: December 30, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–123 Filed 1–6–06; 8:45 am]
National Institute of Dental &
Craniofacial Research; Notice of
Meeting
cprice-sewell on PROD1PC66 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Dental and
Craniofacial Research Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Dental and Craniofacial Research Council.
Date: January 23, 2006.
Open: 8:30 a.m. to 1 p.m.
Agenda: Director’s Report, Budget Report,
Operating Procedures, Training Discussion.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Closed: 2 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
VerDate Aug<31>2005
15:31 Jan 06, 2006
Jkt 208001
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Contact Person: Norman S. Braveman,
PhD, Assistant to the Director, NIH–NIDCR,
Building 31, Rm. 5B55, Bethesda, MD 20892.
301–594–2089. norman.braveman@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, Specialized Neuroscience
Research Program Review.
Date: January 10–12, 2006.
Time: 7 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Excelsior Hotel, 45 West 81st
Street, New York, NY 10024.
Contact Person: Phillip F. Wiethorn,
Scientific Review Administrator, DHHS/NIH/
NINDS/DER/SRB, 6001 Executive Boulevard;
MSC 9529, Neuroscience Center; Room 3203,
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Bethesda, MD 20892–9529. (301) 496–5388.,
wiethorp@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: December 30, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–124 Filed 1–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, National
Institute of Neurological Disorders and
Stroke.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Neurological
Disorders and Stroke, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: January 29–31, 2006.
Time: January 29, 2006, 7 p.m. to 10 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Time: January 30, 2006, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room A, Rockville,
MD 20852.
Time: January 30, 2006, 6 p.m. to 9 p.m.
E:\FR\FM\09JAN1.SGM
09JAN1
Federal Register / Vol. 71, No. 5 / Monday, January 9, 2006 / Notices
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Time: January 31, 2006, 8:30 a.m. to 11:30
a.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Story C. Landis, PhD,
Director, National Institute of Neurological
Disorders and Stroke, NIH, 31 Center Drive,
Building 31, Room 8A52, Bethesda, MD
20892. 301–496–9746.
landiss@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: December 30, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–125 Filed 1–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
cprice-sewell on PROD1PC66 with NOTICES
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Arthritis and Muscoloskeletal
and Skin Diseases Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Aug<31>2005
15:31 Jan 06, 2006
Jkt 208001
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: January 17, 2006.
Open: 8:30 a.m. to 12 p.m.
Agenda: This meeting will be open to the
public to discuss administrative details
relating to Council business and special
reports.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Closed: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Contact Person: Cheryl Kitt, PhD, Director,
Extramural Program, National Institute of
Arthritis and Musculoskeletal and Skin
Diseases, 1 Democracy Blvd., Suite 800,
Bethesda, MD 20892. (301) 594–2463.
kittc@niams.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and signin at the security desk upon entering the
building.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: December 30, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–126 Filed 1–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
1439
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Novel
Therapy for Marijuana Addiction.
Date: January 11, 2006.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Eric Zatman, Contract
Review Specialist, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Room 220, MSC 8401, 6101
Executive Boulevard, Bethesda, MD 20892–
8401, (301) 435–1438.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes on Health,
HHS)
Dated: December 28, 2005.
Anna Snouffer,
Acting Director, Office Federal Advisory
Committee Policy.
[FR Doc. 06–128 Filed 1–16–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\09JAN1.SGM
09JAN1
]]>Agencies
[Federal Register Volume 71, Number 5 (Monday, January 9, 2006)]
[Notices]
[Pages 1438-1439]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-125]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Board of Scientific Counselors, National Institute of Neurological
Disorders and Stroke.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Neurological Disorders and Stroke, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Institute of Neurological Disorders and Stroke.
Date: January 29-31, 2006.
Time: January 29, 2006, 7 p.m. to 10 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: January 30, 2006, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Conference Room A, Rockville, MD 20852.
Time: January 30, 2006, 6 p.m. to 9 p.m.
[[Page 1439]]
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: January 31, 2006, 8:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Story C. Landis, PhD, Director, National
Institute of Neurological Disorders and Stroke, NIH, 31 Center
Drive, Building 31, Room 8A52, Bethesda, MD 20892. 301-496-9746.
landiss@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: December 30, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-125 Filed 1-6-06; 8:45 am]
BILLING CODE 4140-01-M
